SANTA CLARA, Calif., Aug. 12 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: http://www.newcardio.com . Select questions for the conference call will also be taken via email at email@example.com  and can be sent any time prior to the conference call's starting time. A replay of the call will be available by dialing 1-877-870-5176 (domestic) or 1-858-384-5517 (international) and referencing passcode 4339629.
About NewCardio, Inc.
NewCardio  is a cardiac diagnostic and services company developing and marketing proprietary software platform technologies  to provide higher accuracy to, and increase the value of, the standard 12-lead ECG. NewCardio's 3D ECG software platform reduces the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. NewCardio's software products and services significantly improve the diagnosis and monitoring of cardiovascular disease, as well as cardiac safety assessment of drugs under development. For more information, visit www.newcardio.com .
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements containe